IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caxton Corp

Q4 2023 Holdings

Filed 2024-02-14 | 12 holdings | $18.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Xeris Biopharma Holdings Inc(XERS)COM98422E103$13.3M5,641,92071.6%
Savara Inc(SVRA)COM805111101$1.7M353,4419.0%
Rezolute Inc(RZLT)COM NEW76200L309$1.3M1,318,9677.1%
Spdr S&P 500 ETF TR(SPY)TR UNIT78462F103$628.1K1,3223.4%
Molecular Templates IncCOM NEW608550208$510.5K136,8662.8%
Berkshire Hathaway Inc del(BRK/B)CL B NEW084670702$369.3K1,0352.0%
Apogee Therapeutics Inc(APGE)COM03770N101$205.4K7,3531.1%
Abivax SA(ABVX)SPONSORED ADS00370M103$179.1K16,7431.0%
Lexeo Therapeutics Inc(LXEO)COM52886X107$138.5K10,3190.7%
Harpoon Therapeutics IncCOM NEW41358P205$129.3K13,1760.7%
Compass Therapeutics Inc(CMPX)COM20454B104$67.8K43,4650.4%
Allakos Inc(ALLKGUSD)COM01671P100$67.5K24,7100.4%